Cymbalta and Lexapro are alike and different in many ways. Both are commonly taken to treat depression and anxiety disorders. But Cymbalta is approved to treat other conditions as well. They also ...

Anxiety is an experience marked by concern or dread that can manifest in diverse forms, affecting day-to-day life both positively and negatively. Buspirone and Lexapro are categorized under drug ...

I started taking the antidepressant medication Lexapro for anxiety back when I was in my early teens. Since starting, I could tell it helped, but I never wanted to be on it my whole life. In January ...

Healthcare professionals may recommend tapering off antidepressants, like Lexapro, if you experience ... symptoms may start when about 90% of the drug has left your body. The table below lists ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...

The US Food and Drug Administration has approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor agonist (GLP-1 RA) liraglutide (Victoza, Novo Nordisk) to lower ...

Hopefully, the approval will help prevent shortages triggered by demand for injectable weight loss drugs such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) There is still no ...

In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic ...

The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who are 10 years old and up with Type 2 diabetes. The liraglutide ...

Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours ...